 |
Tuesday, June 25, 2019NIAID Launches Large TB Prevention Trial for People Exposed to Multidrug-Resistant TB A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis (MDR-TB) has begun. The study is comparing the safety and efficacy of a new MDR-TB drug, delamanid, with the decades-old TB drug isoniazid for preventing active MDR-TB disease in children, adolescents and adults at high risk who are exposed to adult household members with MDR-TB. |
Los avances de la medicina en el campo de la genética, por ende de la herencia, están modificando el paisaje del conocimiento médico de las enfermedades. Este BLOG intenta informar acerca de los avances proveyendo orientación al enfermo y su familia así como información científica al profesional del equipo de salud de habla hispana.
martes, 25 de junio de 2019
NIH Launches Large TB Prevention Trial for People Exposed to Multidrug-Resistant TB | NIH: National Institute of Allergy and Infectious Diseases
NIH Launches Large TB Prevention Trial for People Exposed to Multidrug-Resistant TB | NIH: National Institute of Allergy and Infectious Diseases
No hay comentarios:
Publicar un comentario